tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CALT

CALT Upcoming Earnings Report: What to Expect?
Pre-EarningsCALT Upcoming Earnings Report: What to Expect?
4M ago
CALT
Calliditas Therapeutics Sets Delisting Process
PremiumCompany Announcements
Calliditas Therapeutics Sets Delisting Process
6M ago
6K
CALT
Calliditas Therapeutics to apply for delisting of common shares, ADSs
PremiumThe Fly
Calliditas Therapeutics to apply for delisting of common shares, ADSs
6M ago
CALT
Calliditas Therapeutics Sees Strong Sales Growth
PremiumCompany Announcements
Calliditas Therapeutics Sees Strong Sales Growth
6M ago
6K
CALT
CALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
CALT
Calliditas Therapeutics’ Share Capital and Votes Increase
PremiumCompany AnnouncementsCalliditas Therapeutics’ Share Capital and Votes Increase
7M ago
6K
CALT
Calliditas’ Setanaxib Shows Promise in PBC Trial
Premium
Company Announcements
Calliditas’ Setanaxib Shows Promise in PBC Trial
7M ago
6K
CALT
Calliditas announces partner approval, EUR 10M milestone payment
Premium
The Fly
Calliditas announces partner approval, EUR 10M milestone payment
7M ago
CALT
Calliditas Therapeutics announces TRANSFORM trial met primary endpoint
PremiumThe Fly
Calliditas Therapeutics announces TRANSFORM trial met primary endpoint
7M ago
CALT
Calliditas says partner initiated Phase III Nefecon trial in Japan
PremiumThe Fly
Calliditas says partner initiated Phase III Nefecon trial in Japan
8M ago
CALT
Calliditas Therapeutics announces USPTO issues patent for setanaxib
PremiumThe Fly
Calliditas Therapeutics announces USPTO issues patent for setanaxib
8M ago
CALT
Calliditas Therapeutics’ Annual Meeting Highlights
PremiumCompany Announcements
Calliditas Therapeutics’ Annual Meeting Highlights
8M ago
6K
CALT
Calliditas Therapeutics downgraded to Hold from Buy at Pareto
PremiumThe FlyCalliditas Therapeutics downgraded to Hold from Buy at Pareto
9M ago
CALT
Calliditas Therapeutics downgraded to Hold from Buy at SEB Equities
Premium
The Fly
Calliditas Therapeutics downgraded to Hold from Buy at SEB Equities
9M ago
CALT
Wynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
Premium
The Fly
Wynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
9M ago
O
BZH
Calliditas Therapeutics downgraded to Neutral from Buy at Citi
PremiumThe Fly
Calliditas Therapeutics downgraded to Neutral from Buy at Citi
9M ago
CALT
CHMP Endorses Calliditas’ Kinpeygo for IgAN
PremiumCompany Announcements
CHMP Endorses Calliditas’ Kinpeygo for IgAN
9M ago
6K
CALT
Calliditas Therapeutics downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Calliditas Therapeutics downgraded to Hold from Buy at Jefferies
9M ago
CALT
Calliditas Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Calliditas Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
9M ago
CALT
Calliditas Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe FlyCalliditas Therapeutics downgraded to Hold from Buy at Stifel
9M ago
CALT
Calliditas Therapeutics presents data at European Renal Association Congress
Premium
The Fly
Calliditas Therapeutics presents data at European Renal Association Congress
9M ago
CALT
M&A News: Asahi Kasei Offers to Acquire Calliditas in $1.1 Billion Deal
Premium
Market News
M&A News: Asahi Kasei Offers to Acquire Calliditas in $1.1 Billion Deal
9M ago
CALT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >